How have LBTSF shares performed in 2024?

Almirall's stock was trading at $9.10 at the start of the year. Since then, LBTSF shares have increased by 4.5% and is now trading at $9.51. View the best growth stocks for 2024 here .

How do I buy shares of Almirall?

Shares of LBTSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:LBTSF

Almirall (LBTSF) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free LBTSF Stock Alerts

$9.51

0.00 (0.00%)

(As of 04/18/2024 ET)

Compare

Today's Range: $9.51
▼
$9.51
50-Day Range: $9.51
▼
$9.51
52-Week Range: $8.85
▼
$10.18

Volume: N/A
Average Volume: 200 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Headlines Short Interest

Get Almirall alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Almirall Stock (OTCMKTS:LBTSF)

Almirall, S.A., a biopharmaceutical company, engages in the purchase, manufacture, storage, and sale of skin-health medicines in Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising actinic keratosis, atopic dermatitis, alopecia areata, skin cancer, psoriasis, onychomycosis, vitiligo, hidradenitis suppurativa, oncodermatology, acne, orphan indications, and rare skin diseases, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, respiratory, and nervous system; dermatologicals; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations. It has a multi-target alliance with Etherna to research and develop new mRNA-based therapies for severe skin diseases, including non-melanoma skin cancer. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.

LBTSF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

LBTSF Stock News Headlines

February 20, 2024 | msn.com

Almirall, S.A. reports FY results

February 19, 2024 | finance.yahoo.com

Almirall continues its progress to leadership in Medical Dermatology driven by strong growth in the European Dermatology business

April 19, 2024 | Behind the Markets (Ad)

Will this $2 AI stock double overnight?

It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!

February 5, 2024 | msn.com

Almirall and Microsoft partner on AI-powered drug discovery in dermatology

December 12, 2023 | marketwatch.com

Almirall, Etherna Team Up to Develop MRNA-Based Dermatology Therapies

December 12, 2023 | finance.yahoo.com

Almirall and etherna Enter Into a Multi-Target Alliance to Develop mRNA-based Therapies in Medical Dermatology

November 17, 2023 | marketwatch.com

Almirall Shares Rise on European Approval for Skin Drug

November 17, 2023 | finance.yahoo.com

Almirall Receives European Commission Approval of EBGLYSS® (lebrikizumab) for Moderate-to-Severe Atopic Dermatitis

April 19, 2024 | Behind the Markets (Ad)

Will this $2 AI stock double overnight?

It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!

November 15, 2023 | msn.com

Almirall and Absci partner on AI-driven dermatological drug development

November 14, 2023 | finanznachrichten.de

Absci Corporation: Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases

November 14, 2023 | finance.yahoo.com

Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases

November 14, 2023 | msn.com

Absci, Almirall partner on dermatologic drug development

November 9, 2023 | msn.com

Almirall, S.A. reports 9M results

November 9, 2023 | businesswire.com

Almirall’s Nine-month 2023 Results:

October 13, 2023 | businesswire.com

Almirall's Lebrikizumab Improves Signs and Symptoms of Moderate-to-Severe Atopic Dermatitis (AD) in Patients Inadequately Controlled With or Ineligible for Cyclosporine

October 12, 2023 | msn.com

Almirall and EpimAb partner to develop bispecific antibody therapies

October 12, 2023 | businesswire.com

EpimAb Biotherapeutics and Almirall Announce Bispecific Antibody License Agreement

October 11, 2023 | finance.yahoo.com

Almirall's Ilumetri® (tildrakizumab) Significantly Improves Wellbeing for Patients1 and Their Relatives2 in Moderate-to-Severe Plaque Psoriasis

October 10, 2023 | businesswire.com

Centrient Pharmaceuticals joins Almirall’s growing innovation hub in Barcelona

September 18, 2023 | msn.com

EMA’s CHMP supports Almirall’s Ebyglyss for atopic dermatitis

July 24, 2023 | msn.com

Almirall, S.A. reports 1H results

July 7, 2023 | finance.yahoo.com

Almirall: Ilumetri® (tildrakizumab) significantly improved the wellbeing of patients with moderate-to-severe plaque psoriasis

June 13, 2023 | finance.yahoo.com

Almirall announces the pricing and closing of its €200mm non pre-emptive share capital increase

May 8, 2023 | news.yahoo.com

Almirall's Q1 core earnings beat estimates on Europe dermatology operations

May 8, 2023 | finance.yahoo.com

Almirall’s First Quarter 2023 Results

May 8, 2023 | reuters.com

Almirall's core earnings beat estimates in Q1

See More Headlines

Receive LBTSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Almirall and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Current Symbol: OTCMKTS:LBTSF
CUSIP: N/A
CIK: N/A
Web: www.almirall.com
Phone: 34 93 291 30 00
Fax: N/A
Employees: 1,904
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Mr. Carlos Gallardo Piqué (Age 52)
CEO, President, Member of Management Board & Chairman of the Board
Comp: $54.31k
Mr. Michael McClellan (Age 52)
CFO & Member of Management Board
Mr. Eloi Crespo Cervera
Chief Industrial Operations Officer & Member of Management Board
Mr. Esteve Conesa Panicot
Chief People & Culture Officer and Member of Management Board
Dr. Volker Koscielny
Chief Medical Officer & Member of Management Board
Dr. Karl Ziegelbauer
Chief Scientific Officer & Member of Management Board
Mr. Paolo Cionini
Chief Commercial Officer Europe & International and Member of Management Board
Ms. Isabel Cristina Gomes
Company Vice Secretary,Chief Legal Officer, General Counsel & Member of Management Board
Ms. Mercedes Diz Lopez
Chief Marketing Officer & Member of Management Board
Mr. Pablo Divasson del Fraile
Senior Director of Investor Relations

Key Competitors

View All Competitors

LBTSF Stock Analysis - Frequently Asked Questions

How have LBTSF shares performed in 2024?: Almirall's stock was trading at $9.10 at the start of the year. Since then, LBTSF shares have increased by 4.5% and is now trading at $9.51.
View the best growth stocks for 2024 here.
How do I buy shares of Almirall?: Shares of LBTSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:LBTSF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial